Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial

BACKGROUND: Off‐target properties of ticagrelor might reduce microvascular injury and improve clinical outcome in patients with ST‐segment–elevation myocardial infarction. The REDUCE‐MVI (Evaluation of Microvascular Injury in Revascularized Patients with ST‐Segment–Elevation Myocardial Infarction Tr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Am Heart Assoc
Glavni autori: van der Hoeven, Nina W., Janssens, Gladys N., Everaars, Henk, Nap, Alexander, Lemkes, Jorrit S., de Waard, Guus A., van de Ven, Peter M., van Rossum, Albert C., Escaned, Javier, Mejia‐Renteria, Hernan, ten Cate, Tim J. F., Piek, Jan J., von Birgelen, Clemens, Valgimigli, Marco, Diletti, Roberto, Riksen, Niels P., Van Mieghem, Nicolas M., Nijveldt, Robin, van Leeuwen, Maarten A. H., van Royen, Niels
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335553/
https://ncbi.nlm.nih.gov/pubmed/32122216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014411
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items